Medicinal Products

Dáil Éireann Debate, Thursday - 20 June 2024

• Debates
• Find a debate
  • Dáil debates
  • Seanad debates
  • Committee debates
• Find a vote
  • Dáil votes
  • Seanad votes
  • Committee votes
• Parliamentary questions
  • Written questions
  • Oral questions
• Search tips
• Utterances having an adverse effect

Thursday, 20 June 2024

Questions (208)

John Lahart

Question:

208. Deputy John Lahart asked the Minister for Health to provide an update on the availability of the drug skyrizi (risankizumab-rzaa) for patients with severe Crohn’s disease, given the delays due to price negotiations and its current availability in the UK and Europe. [26650/24]

Written answers

Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

• Previous Answer
• Next Answer